Short answer
LifeStance Health Group, Inc. (LFST) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q1 2026 results covered the quarter ended March 31, 2026.
LifeStance Health Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results covered the quarter ended March 31, 2026
- Press release issued May 7, 2026, with financial results furnished as Exhibit 99.1
- Investor focus: Exhibit 99.1 contains the operating metrics and financial details driving valuation
Item 7.01 · Regulation FD Disclosure
- Exhibit 99.2 contains supplemental LifeStance Health Group information for fiscal 2026
- Investor relevance depends on the presentation’s operating and financial metrics and strategic updates
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LifeStance Health Group, Inc. 8-K filings
Get the next LFST 8-K as it lands
Follow LFST for push alerts, or ask the research agent what this filing means.